Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
28.54
+0.66 (2.37%)
At close: Nov 6, 2026, 4:00 PM EST
28.53
-0.01 (-0.04%)
After-hours: Nov 6, 2026, 7:30 PM EST
Parabilis Medicines Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Parabilis Medicines stock has a consensus rating of "Strong Buy" and an average price target of $41.4. The average 1-year stock price forecast is 45.06% higher than the current stock price, while the lowest is $40 (+40.15%) and the highest is $45 (+57.67%).
Price Target: $41.4 (+45.06%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Parabilis Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|
| Strong Buy | 5 | 5 | 6 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +40.15% | Oct 26, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $45 | Buy | Maintains | $45 | +57.67% | Oct 26, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 | Buy | Maintains | $40 | +40.15% | Aug 14, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $42 | Buy | Maintains | $42 | +47.16% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
1.19M
Revenue Next Year
4.75M
from 1.19M
Increased by 300.17%
EPS This Year
-2.58
EPS Next Year
-2.19
from -2.58
EPS and Forward PE are based on non-GAAP adjusted numbers.